Aldosterone in heart and kidney diseases.
Rentoukas
Elias I
EI
Department of Cardiology, G. Gennimatas General Hospital, Athens, Greece.
Lazaros
Georgios A
GA
Zirogiannis
Panos N
PN
D000450:Aldosterone / Q000097:blood / Q000378:metabolism / Q000502:physiology*; D000818:Animals; D002319:Cardiovascular System / Q000503:physiopathology; D004730:Endothelium, Vascular / Q000503:physiopathology; D000077545:Eplerenone; D006331:Heart Diseases / Q000503:physiopathology*; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007674:Kidney Diseases / Q000503:physiopathology*; D000451:Mineralocorticoid Receptor Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D011188:Potassium / Q000097:blood; D012084:Renin-Angiotensin System / Q000502:physiology; D013148:Spironolactone / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use
D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone; D000450:Aldosterone; D000077545:Eplerenone; D011188:Potassium